New York, NY -- (SBWIRE) -- 09/16/2013 -- StockMarketIntel.com issues a special report on the following stocks: NewLead Holdings Ltd (NASDAQ:NEWL), Arch Coal Inc (NYSE:ACI), Golden Star Resources Ltd. (USA) (NYSEMKT:GSS), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX)
In prior session, NewLead Holdings Ltd (NASDAQ:NEWL), scored a big bearish performance of -3.17% and closed the session at the price of $0.110. The market capitalization of the stock remained $43.64 million. The 52 week range of the stock was $0.10- $2.73 and its EPS remained $-16.69. The prior 5 day’s trend of the stock was in the red, as it decreased -4.35% and its one month trend was negative, as it dropped -15.38%. NewLead Holdings Ltd., a shipping and commodity company, is engaged in the transportation of refined products and dry bulk goods worldwide.
Has NEWL Found The Bottom and Ready To Move Up? Find Out Here
Arch Coal Inc (NYSE:ACI) was among the big bears of the prior session, as it dropped -3.30% and finished the day at the closing price of $4.69. The day range of the stock was $4.68- $4.89 and its 52 week range remained $3.47- $8.86. The risk relation factor, Beta of the stock remained 1.85. Arch Coal, Inc. engages in the production and sale of steam and metallurgical coal from surface and underground mines located in the United States.
Has ACI Found The Bottom And Ready To Gain Momentum? Find Out Here
Golden Star Resources Ltd. (USA) (NYSEMKT:GSS) started its trading session with the price of $0.50, and closed at $0.481 by scoring -3.80%. The 52 week range of the stock was $0.40-$2.11. GSS traded with total volume of 2.13 million shares, while the average trading volume remained 2.92 million shares. The beta of the stock stands at 1.12. The day range of the GSS remained $0.48 - $0.52. Golden Star Resources Ltd. engages in the acquisition, exploration, development, and operation of gold properties.
Will GSS Get Buyers Even After The Recent Rally? Find Out Here
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) traded during its last trading session with the total volume of 2.16 million shares, as compared to its average volume of 2.95 million shares. During the previous session, the company’s minimum price was $2.37 while it touched its highest price for the day at $2.59. In most recent session, the stock tumbled -3.95% and closed the trading activity at $2.43. Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders.
Why Should Investors Buy CPRX After the Recent Fall? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)